Adverse Interaction of Low-calcium Diet and Low 25(OH)D Levels on Lumbar Spine Mineralization in Late-pubertal Girls
Overview
Affiliations
No consensus has been reached on the serum 25-hydroxyvitamin D [25(OH)D] levels required to ensure optimal bone health around menarche. We searched for a possible interaction of 25(OH)D levels and calcium intake on lumbar spine mineralization and on biologic features of bone metabolism in healthy late-pubertal girls. Lumbar spine parameters (ie, area, mineral content, and density) and calcium intake were evaluated in 211 healthy white adolescent girls at pubertal stages IV-V (11 to 16.9 years), together with biologic markers of calcium and bone metabolism and with International External Quality Assessment Scheme for Vitamin D Metabolite (DEQAS)-validated serum 25(OH)D levels. A high prevalence of 25(OH)D levels ≤ 30 nmol/L (41%), ≤ 40 nmol/L (61%), and ≤ 50 nmol/L (70%) was found during winter-spring. Parathyroid hormone (PTH) levels were inversely associated with 25(OH)D levels (p = .0021). In contrast, lumbar spine mineral content and density were not associated with 25(OH)D, excepted when calcium intake was below 600 mg/day (p = .0081). Girls with such low calcium intake and 25(OH)D levels of 40 nmol/L or less (9% of the cohort) had a 0.4 to 0.7 SD lower mean areal bone mineral density Z-score than girls with higher calcium intake and/or higher 25(OH)D status. The adverse association between lumbar spine mineralization and combined calcium deficiency-low 25(OH)D levels remained significant in the 91 girls who could be followed over 4 years after their initial evaluation. We conclude that low 25(OH)D levels (≤40 nmol/L) are observed frequently during winter-spring in late-pubertal European girls, which may exacerbate the negative impact of calcium deficiency on lumbar spine mineralization.
Levaillant L, Levaillant M, Sfeir N, Bouhours-Nouet N, Amsellem-Jager J, Beaumesnil M JPGN Rep. 2023; 4(2):e296.
PMID: 37200715 PMC: 10187845. DOI: 10.1097/PG9.0000000000000296.
Hajhashemy Z, Saneei P, Keshteli A, Daghaghzadeh H, Tavakkoli H, Adibi P Sci Rep. 2022; 12(1):7913.
PMID: 35552448 PMC: 9098849. DOI: 10.1038/s41598-022-11597-8.
Chee W, Chang C, Arasu K, Wong S, Ong S, Yang W Nutrients. 2021; 13(7).
PMID: 34202743 PMC: 8308301. DOI: 10.3390/nu13072175.
Lu J, Pan H, Hu X, Huang Z, Zhang Q Osteoporos Int. 2019; 30(11):2231-2239.
PMID: 31375874 PMC: 6811668. DOI: 10.1007/s00198-019-05105-4.
Vitamin D in children with growth hormone deficiency due to pituitary stalk interruption syndrome.
Delecroix C, Brauner R, Souberbielle J BMC Pediatr. 2018; 18(1):11.
PMID: 29368588 PMC: 5784716. DOI: 10.1186/s12887-018-0992-3.